Home LiteratureArticle Details
PMID: 9858506 Published · ppublish English Comment Journal Article Review

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses.

The Journal of experimental medicine ·Vol. 188 ·No. 12 ·1998-12-21 ·Pages 2199-204

Kalams SA, Walker BD

Abstract

暂无摘要

MeSH Terms
Animals Arenaviridae Infections/immunology Clonal Anergy/immunology HIV Infections/immunology,therapy,virology Humans Lymphocyte Cooperation Lymphocytic choriomeningitis virus T-Lymphocytes, Cytotoxic/immunology T-Lymphocytes, Helper-Inducer/immunology Virus Diseases/immunology
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Kalams S A
Partners AIDS Research Center and Infectious Disease Division, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, USA.kalams@helix.mgh.harvard.edu
Walker B D
References (50)
50 references, click to expand
  1. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.
    N Engl J Med. 1995 Oct 19;333(16):1038-44 PMID: 7675046
  2. Serial triggering of many T-cell receptors by a few peptide-MHC complexes.
    Nature. 1995 May 11;375(6527):148-51 PMID: 7753171
  3. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes.
    Immunity. 1996 Jan;4(1):25-36 PMID: 8574849
  4. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection.
    Nat Med. 1996 Apr;2(4):405-11 PMID: 8597949
  5. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response.
    Immunity. 1996 Jun;4(6):565-71 PMID: 8673703
  6. T cell activation determined by T cell receptor number and tunable thresholds.
    Science. 1996 Jul 5;273(5271):104-6 PMID: 8658175
  7. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection.
    AIDS Res Hum Retroviruses. 1996 May 1;12(7):585-92 PMID: 8743084
  8. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy.
    J Exp Med. 1996 Apr 1;183(4):1917-21 PMID: 8666949
  9. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.
    J Virol. 1996 Sep;70(9):5799-806 PMID: 8709196
  10. Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies [corrected].
    Nature. 1996 Aug 22;382(6593):726-9 PMID: 8751445
  11. Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile.
    Immunol Lett. 1996 Jun;51(1-2):107-14 PMID: 8811353
  12. Phenotypic analysis of antigen-specific T lymphocytes.
    Science. 1996 Oct 4;274(5284):94-6 PMID: 8810254
  13. Hepatitis C.
    Ann Intern Med. 1996 Oct 15;125(8):658-68 PMID: 8849151
  14. Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival.
    J Virol. 1997 Jan;71(1):284-90 PMID: 8985348
  15. Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells.
    J Exp Med. 1996 Sep 1;184(3):863-71 PMID: 9064346
  16. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms.
    J Virol. 1997 Apr;71(4):3120-8 PMID: 9060675
  17. A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers.
    Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6874-9 PMID: 9192659
  18. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.
    Science. 1997 Jul 4;277(5322):112-6 PMID: 9204894
  19. Single cell analysis reveals regulated hierarchical T cell antigen receptor signaling thresholds and intraclonal heterogeneity for individual cytokine responses of CD4+ T cells.
    J Exp Med. 1997 Aug 29;186(5):757-66 PMID: 9271591
  20. Frequency of HLA allele-specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection.
    Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9802-7 PMID: 9275206
  21. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.
    Science. 1997 Nov 21;278(5342):1447-50 PMID: 9367954
  22. The duration of antigenic stimulation determines the fate of naive and effector T cells.
    Immunity. 1998 Jan;8(1):89-95 PMID: 9462514
  23. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection.
    Immunity. 1998 Feb;8(2):167-75 PMID: 9491998
  24. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.
    Immunity. 1998 Feb;8(2):177-87 PMID: 9491999
  25. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans.
    Nature. 1998 Feb 26;391(6670):908-11 PMID: 9495345
  26. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.
    Science. 1998 Mar 27;279(5359):2103-6 PMID: 9516110
  27. Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes.
    Curr Biol. 1998 Mar 12;8(6):355-8 PMID: 9512422
  28. HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism.
    J Exp Med. 1998 Apr 6;187(7):1113-22 PMID: 9529327
  29. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection.
    J Immunol. 1998 Feb 1;160(3):1479-88 PMID: 9570570
  30. A new look at T cells.
    J Exp Med. 1998 May 4;187(9):1367-71 PMID: 9565629
  31. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes.
    J Exp Med. 1998 May 4;187(9):1383-93 PMID: 9565631
  32. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo.
    J Exp Med. 1998 May 4;187(9):1395-402 PMID: 9565632
  33. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.
    Nature. 1998 Jun 4;393(6684):474-8 PMID: 9624003
  34. Help for cytotoxic-T-cell responses is mediated by CD40 signalling.
    Nature. 1998 Jun 4;393(6684):478-80 PMID: 9624004
  35. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.
    Nature. 1998 Jun 4;393(6684):480-3 PMID: 9624005
  36. Stability of virus-specific CD4+ T cell frequencies from acute infection into long term memory.
    J Immunol. 1998 Jul 1;161(1):367-74 PMID: 9647245
  37. Critical role for CD4(+) T cells in controlling retrovirus replication and spread in persistently infected mice.
    J Virol. 1998 Aug;72(8):6559-64 PMID: 9658100
  38. Viral immune evasion due to persistence of activated T cells without effector function.
    J Exp Med. 1998 Dec 21;188(12):2205-13 PMID: 9858507
  39. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.
    J Virol. 1996 Feb;70(2):1072-9 PMID: 8551565
  40. T4+ T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses.
    J Virol. 1988 Jun;62(6):2102-6 PMID: 2966865
  41. Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4.
    Nature. 1991 Sep 12;353(6340):180-4 PMID: 1832488
  42. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.
    J Exp Med. 1992 Jul 1;176(1):157-68 PMID: 1319456
  43. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
    J Exp Med. 1992 Jul 1;176(1):169-76 PMID: 1377222
  44. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
    J Exp Med. 1993 Feb 1;177(2):249-56 PMID: 8093890
  45. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.
    J Virol. 1993 Dec;67(12):7522-32 PMID: 7693974
  46. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice.
    Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3764-8 PMID: 8170985
  47. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice.
    J Virol. 1994 Jul;68(7):4700-4 PMID: 7911534
  48. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
    J Virol. 1994 Dec;68(12):8056-63 PMID: 7966595
  49. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression.
    J Virol. 1995 Feb;69(2):1059-70 PMID: 7815484
  50. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.
    J Exp Med. 1995 Apr 1;181(4):1365-72 PMID: 7699324
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
DOI
10.1084/jem.188.12.2199
Email
usa.kalams@helix.mgh.harvard.edu
Published
1998-12-21
Pages
2199-204
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2212425
Subset
IM
Corrections
CommentOn
PMID: 9858507
External Links
PubMed source DOI: 10.1084/jem.188.12.2199 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2